Dr. Holly Harper Reid, MD

Dr. Reid practices at The Woodlands Dermatology Associates PA in Spring, Texas.

Dr. Reid's NPI, 1558756817, was assigned on April 3, 2015. Dr. Reid graduated from McGovern Medical School in 2015. Dr. Reid holds Texas license R9844.

Dr. Reid's primary practice is The Woodlands Dermatology Associates PA, at 9303 Pinecroft Dr, Spring, TX 77380 in Montgomery County. The practice phone is (281) 363-5050.

Dr. Reid's primary practice is The Woodlands Dermatology Associates PA in Spring, Texas. The medical group on file is The Woodlands Dermatology Associates. Dmand AI also links Dr. Reid to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reid practices. Vendor and product names are available with a free account.

Dermatology is Dr. Reid's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Reid is board certified in dermatology by the American Board of Dermatology. Dr. Reid is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and joint cyst among the conditions Dr. Reid treats.

CMS data shows 1,986 Medicare services from Dr. Reid across 17 procedure codes in 2024, for 745 Medicare patients. Medicare paid $110,253 for them. Every service was in an office.

CMS counts 745 Medicare patients who saw Dr. Reid in 2024. The largest group is 65 to 74, with 434 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reid's median patient age at 58, with 69% women.

In 2024, Dr. Reid wrote 1,052 Medicare Part D claims for 351 patients. 98% of them were for generic drugs. CMS names the drug for 970 of them, across 12 drugs with 11 or more claims each, at $17,508 in total drug cost. In 2023, CMS named 792 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reid for performance year 2024, reported as part of a group. Dr. Reid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 395 procedures of skin biopsy by Dr. Reid, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Reid, published from 2015 to 2019. Dr. Reid's most frequent co-authors are Erich M. Sturgis, MD, Savina Aneja and Steven Bennett Chinn, MD.

CMS Open Payments shows 392 general payments to Dr. Reid from 22 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,806.

Dr. Reid graduated from McGovern Medical School in 2015.

Dr. Reid is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.